<svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 800 1200" width="800" height="1200">
  <defs>
    <linearGradient id="headerGrad" x1="0%" y1="0%" x2="100%" y2="0%">
      <stop offset="0%" style="stop-color:#1e3a8a"/>
      <stop offset="100%" style="stop-color:#7c3aed"/>
    </linearGradient>
    <linearGradient id="blueGrad" x1="0%" y1="0%" x2="0%" y2="100%">
      <stop offset="0%" style="stop-color:#3b82f6"/>
      <stop offset="100%" style="stop-color:#1d4ed8"/>
    </linearGradient>
  </defs>
  
  <!-- Background -->
  <rect width="800" height="1200" fill="#f8fafc"/>
  
  <!-- Header -->
  <rect width="800" height="140" fill="url(#headerGrad)"/>
  <text x="400" y="60" text-anchor="middle" fill="white" font-family="Arial, sans-serif" font-size="32" font-weight="bold">Peptide Therapy Market</text>
  <text x="400" y="95" text-anchor="middle" fill="#e0e7ff" font-family="Arial, sans-serif" font-size="24">2026 Industry Statistics</text>
  <text x="400" y="125" text-anchor="middle" fill="#c7d2fe" font-family="Arial, sans-serif" font-size="14">Source: pepedhub.com/statistics</text>
  
  <!-- Market Size Section -->
  <rect x="40" y="160" width="720" height="180" rx="12" fill="white" stroke="#e2e8f0" stroke-width="2"/>
  <text x="60" y="195" fill="#1e3a8a" font-family="Arial, sans-serif" font-size="18" font-weight="bold">Global Peptide Market Size</text>
  
  <!-- 2024 Box -->
  <rect x="60" y="215" width="200" height="100" rx="8" fill="#dbeafe"/>
  <text x="160" y="255" text-anchor="middle" fill="#1e40af" font-family="Arial, sans-serif" font-size="36" font-weight="bold">$49.5B</text>
  <text x="160" y="285" text-anchor="middle" fill="#3b82f6" font-family="Arial, sans-serif" font-size="14">2024 Market</text>
  
  <!-- Arrow -->
  <path d="M280 265 L340 265" stroke="#10b981" stroke-width="4" fill="none" marker-end="url(#arrowhead)"/>
  <text x="310" y="250" text-anchor="middle" fill="#10b981" font-family="Arial, sans-serif" font-size="14" font-weight="bold">+64%</text>
  
  <!-- 2034 Box -->
  <rect x="360" y="215" width="200" height="100" rx="8" fill="#dcfce7"/>
  <text x="460" y="255" text-anchor="middle" fill="#166534" font-family="Arial, sans-serif" font-size="36" font-weight="bold">$81.5B</text>
  <text x="460" y="285" text-anchor="middle" fill="#22c55e" font-family="Arial, sans-serif" font-size="14">2034 Projected</text>
  
  <!-- CAGR Box -->
  <rect x="580" y="215" width="160" height="100" rx="8" fill="#fef3c7"/>
  <text x="660" y="255" text-anchor="middle" fill="#92400e" font-family="Arial, sans-serif" font-size="28" font-weight="bold">5.1%</text>
  <text x="660" y="285" text-anchor="middle" fill="#d97706" font-family="Arial, sans-serif" font-size="14">CAGR</text>
  
  <!-- GLP-1 Section -->
  <rect x="40" y="360" width="720" height="200" rx="12" fill="white" stroke="#e2e8f0" stroke-width="2"/>
  <text x="60" y="395" fill="#1e3a8a" font-family="Arial, sans-serif" font-size="18" font-weight="bold">GLP-1 Agonist Market Dominance</text>
  
  <!-- GLP-1 Stats -->
  <rect x="60" y="415" width="160" height="120" rx="8" fill="#ede9fe"/>
  <text x="140" y="465" text-anchor="middle" fill="#5b21b6" font-family="Arial, sans-serif" font-size="28" font-weight="bold">$24.2B</text>
  <text x="140" y="490" text-anchor="middle" fill="#7c3aed" font-family="Arial, sans-serif" font-size="12">GLP-1 Market</text>
  <text x="140" y="515" text-anchor="middle" fill="#10b981" font-family="Arial, sans-serif" font-size="14" font-weight="bold">+67% YoY</text>
  
  <rect x="240" y="415" width="160" height="120" rx="8" fill="#dbeafe"/>
  <text x="320" y="465" text-anchor="middle" fill="#1e40af" font-family="Arial, sans-serif" font-size="28" font-weight="bold">$21.1B</text>
  <text x="320" y="490" text-anchor="middle" fill="#3b82f6" font-family="Arial, sans-serif" font-size="12">Semaglutide</text>
  <text x="320" y="515" text-anchor="middle" fill="#10b981" font-family="Arial, sans-serif" font-size="14" font-weight="bold">+42% YoY</text>
  
  <rect x="420" y="415" width="160" height="120" rx="8" fill="#fce7f3"/>
  <text x="500" y="465" text-anchor="middle" fill="#9d174d" font-family="Arial, sans-serif" font-size="28" font-weight="bold">$8.5B</text>
  <text x="500" y="490" text-anchor="middle" fill="#ec4899" font-family="Arial, sans-serif" font-size="12">Tirzepatide</text>
  <text x="500" y="515" text-anchor="middle" fill="#10b981" font-family="Arial, sans-serif" font-size="14" font-weight="bold">+156% YoY</text>
  
  <rect x="600" y="415" width="140" height="120" rx="8" fill="#dcfce7"/>
  <text x="670" y="465" text-anchor="middle" fill="#166534" font-family="Arial, sans-serif" font-size="28" font-weight="bold">15.5M</text>
  <text x="670" y="490" text-anchor="middle" fill="#22c55e" font-family="Arial, sans-serif" font-size="12">US Patients</text>
  <text x="670" y="515" text-anchor="middle" fill="#10b981" font-family="Arial, sans-serif" font-size="14" font-weight="bold">+89%</text>
  
  <!-- Clinical Trials Section -->
  <rect x="40" y="580" width="720" height="160" rx="12" fill="white" stroke="#e2e8f0" stroke-width="2"/>
  <text x="60" y="615" fill="#1e3a8a" font-family="Arial, sans-serif" font-size="18" font-weight="bold">Clinical Research Activity</text>
  
  <rect x="60" y="635" width="160" height="80" rx="8" fill="#f0fdf4"/>
  <text x="140" y="675" text-anchor="middle" fill="#166534" font-family="Arial, sans-serif" font-size="32" font-weight="bold">2,847</text>
  <text x="140" y="700" text-anchor="middle" fill="#22c55e" font-family="Arial, sans-serif" font-size="11">Active Peptide Trials</text>
  
  <rect x="240" y="635" width="160" height="80" rx="8" fill="#fef3c7"/>
  <text x="320" y="675" text-anchor="middle" fill="#92400e" font-family="Arial, sans-serif" font-size="32" font-weight="bold">892</text>
  <text x="320" y="700" text-anchor="middle" fill="#d97706" font-family="Arial, sans-serif" font-size="11">GLP-1 Trials</text>
  
  <rect x="420" y="635" width="160" height="80" rx="8" fill="#ede9fe"/>
  <text x="500" y="675" text-anchor="middle" fill="#5b21b6" font-family="Arial, sans-serif" font-size="32" font-weight="bold">127</text>
  <text x="500" y="700" text-anchor="middle" fill="#7c3aed" font-family="Arial, sans-serif" font-size="11">BPC-157 Studies</text>
  
  <rect x="600" y="635" width="140" height="80" rx="8" fill="#dbeafe"/>
  <text x="670" y="675" text-anchor="middle" fill="#1e40af" font-family="Arial, sans-serif" font-size="32" font-weight="bold">23</text>
  <text x="670" y="700" text-anchor="middle" fill="#3b82f6" font-family="Arial, sans-serif" font-size="11">FDA Approvals (5yr)</text>
  
  <!-- Provider Adoption Section -->
  <rect x="40" y="760" width="720" height="160" rx="12" fill="white" stroke="#e2e8f0" stroke-width="2"/>
  <text x="60" y="795" fill="#1e3a8a" font-family="Arial, sans-serif" font-size="18" font-weight="bold">Healthcare Provider Adoption</text>
  
  <rect x="60" y="815" width="160" height="80" rx="8" fill="#fce7f3"/>
  <text x="140" y="855" text-anchor="middle" fill="#9d174d" font-family="Arial, sans-serif" font-size="32" font-weight="bold">34%</text>
  <text x="140" y="880" text-anchor="middle" fill="#ec4899" font-family="Arial, sans-serif" font-size="10">Providers Prescribing</text>
  
  <rect x="240" y="815" width="160" height="80" rx="8" fill="#dcfce7"/>
  <text x="320" y="855" text-anchor="middle" fill="#166534" font-family="Arial, sans-serif" font-size="32" font-weight="bold">312%</text>
  <text x="320" y="880" text-anchor="middle" fill="#22c55e" font-family="Arial, sans-serif" font-size="10">Demand Increase</text>
  
  <rect x="420" y="815" width="160" height="80" rx="8" fill="#dbeafe"/>
  <text x="500" y="855" text-anchor="middle" fill="#1e40af" font-family="Arial, sans-serif" font-size="32" font-weight="bold">28%</text>
  <text x="500" y="880" text-anchor="middle" fill="#3b82f6" font-family="Arial, sans-serif" font-size="10">Pharmacy Growth</text>
  
  <rect x="600" y="815" width="140" height="80" rx="8" fill="#fef3c7"/>
  <text x="670" y="855" text-anchor="middle" fill="#92400e" font-family="Arial, sans-serif" font-size="32" font-weight="bold">67%</text>
  <text x="670" y="880" text-anchor="middle" fill="#d97706" font-family="Arial, sans-serif" font-size="10">Telehealth Rx</text>
  
  <!-- Top Peptides Section -->
  <rect x="40" y="940" width="720" height="180" rx="12" fill="white" stroke="#e2e8f0" stroke-width="2"/>
  <text x="60" y="975" fill="#1e3a8a" font-family="Arial, sans-serif" font-size="18" font-weight="bold">Most Prescribed Peptides by Market Share</text>
  
  <!-- Bar Chart -->
  <rect x="80" y="1000" width="280" height="24" rx="4" fill="#3b82f6"/>
  <text x="90" y="1017" fill="white" font-family="Arial, sans-serif" font-size="12" font-weight="bold">Semaglutide - 38%</text>
  
  <rect x="80" y="1030" width="110" height="24" rx="4" fill="#8b5cf6"/>
  <text x="90" y="1047" fill="white" font-family="Arial, sans-serif" font-size="12" font-weight="bold">Tirzepatide - 15%</text>
  
  <rect x="80" y="1060" width="60" height="24" rx="4" fill="#10b981"/>
  <text x="90" y="1077" fill="white" font-family="Arial, sans-serif" font-size="12" font-weight="bold">BPC-157 - 8%</text>
  
  <rect x="80" y="1090" width="45" height="24" rx="4" fill="#f59e0b"/>
  <text x="90" y="1107" fill="white" font-family="Arial, sans-serif" font-size="11" font-weight="bold">CJC/Ipa - 6%</text>
  
  <!-- Legend -->
  <text x="420" y="1020" fill="#64748b" font-family="Arial, sans-serif" font-size="12">Weight Loss Peptides</text>
  <text x="420" y="1045" fill="#64748b" font-family="Arial, sans-serif" font-size="12">Healing Peptides</text>
  <text x="420" y="1070" fill="#64748b" font-family="Arial, sans-serif" font-size="12">GH Secretagogues</text>
  <text x="420" y="1095" fill="#64748b" font-family="Arial, sans-serif" font-size="12">Cognitive/Immune</text>
  
  <!-- Footer -->
  <rect x="0" y="1140" width="800" height="60" fill="#1e3a8a"/>
  <text x="400" y="1165" text-anchor="middle" fill="white" font-family="Arial, sans-serif" font-size="14">Data compiled from FDA, ClinicalTrials.gov, Industry Reports | Updated February 2026</text>
  <text x="400" y="1185" text-anchor="middle" fill="#93c5fd" font-family="Arial, sans-serif" font-size="12">pepedhub.com - The Peptide Education Hub</text>
</svg>
